(Q42784716)

7 November 2017

title

A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms (English)

1 reference

7 November 2017

1 reference

F. Gillison

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21137117

19 November 2024

E. J. McGrath

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21137117

19 November 2024

C. R. Lovell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21137117

19 November 2024

A. Darvay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21137117

19 November 2024

J. R. Hickey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21137117

19 November 2024

S. M. Skevington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21137117

19 November 2024

language of work or name

English

0 references

publication date

1 December 2010

1 reference

7 November 2017

December 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21137117

full work available at URL

19 November 2024

https://purehost.bath.ac.uk/ws/files/133323108/acne_qol_14_Sept_09.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21137117

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2133.2010.10060.x

19 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2010.10060.x/fullpdf

19 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

British Journal of Dermatology

19 November 2024

published in

1 reference

7 November 2017

volume

163

1 reference

7 November 2017

1 reference

7 November 2017

page(s)

1323-1329

1 reference

Acne vulgaris: a disease of Western civilization

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Prevalence of facial acne vulgaris in late adolescence and in adults

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Effect of isotretinoin on the quality of life of patients with acne.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

The quality of life in acne: a comparison with general medical conditions using generic questionnaires.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Quality of life issues for South Africans with acne vulgaris

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Acne, isotretinoin and depression

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

An analysis of reports of depression and suicide in patients treated with isotretinoin

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Suicide, depression, and isotretinoin: is there a causal link?

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Practical use of a disability index in the routine management of acne

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI).

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Validation of WHO QOL-BREF instrument in Indian adolescents

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Prediction of major depression and dysthymia from CES-D scores among ethnic minority adolescents

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Children's symptom and social functioning self-report scales. Comparison of mothers' and children's reports

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Measurement adequacy of the CES-D among a sample of older African-Americans

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Changes in the quality of life of patients receiving antidepressant medication in primary care: validation of the WHOQOL-100.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Isotretinoin and psychopathology: a review

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Retinoid-mediated regulation of mood: possible cellular mechanisms.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Functional brain imaging alterations in acne patients treated with isotretinoin

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Self-esteem and body satisfaction among late adolescents with acne: results from a population survey

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts.

19 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2010.10060.X

19 November 2024

Identifiers

DOI

1 reference

7 November 2017

1 reference